GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » Altman Z-Score

Symmetry Surgical (FRA:RZV) Altman Z-Score : 1.87 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Symmetry Surgical Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Symmetry Surgical has a Altman Z-Score of 1.87, indicating it is in Grey Zones. This implies that Symmetry Surgical is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Symmetry Surgical's Altman Z-Score or its related term are showing as below:

FRA:RZV' s Altman Z-Score Range Over the Past 10 Years
Min: 0.69   Med: 2.5   Max: 6.8
Current: 1.87

During the past 13 years, Symmetry Surgical's highest Altman Z-Score was 6.80. The lowest was 0.69. And the median was 2.50.


Symmetry Surgical Altman Z-Score Historical Data

The historical data trend for Symmetry Surgical's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical Altman Z-Score Chart

Symmetry Surgical Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 2.63 1.39 1.91 1.70

Symmetry Surgical Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.56 1.70 1.69 1.56 1.99

Competitive Comparison of Symmetry Surgical's Altman Z-Score

For the Medical Devices subindustry, Symmetry Surgical's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symmetry Surgical's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's Altman Z-Score falls into.



Symmetry Surgical Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Symmetry Surgical's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1925+1.4*-0.0264+3.3*0.0026+0.6*1.5046+1.0*0.7614
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2014:
Total Assets was €396.8 Mil.
Total Current Assets was €117.3 Mil.
Total Current Liabilities was €41.0 Mil.
Retained Earnings was €-10.5 Mil.
Pre-Tax Income was 1.333 + -3.33 + 1.477 + -6.25 = €-6.8 Mil.
Interest Expense was -1.592 + -1.552 + -1.607 + -3.044 = €-7.8 Mil.
Revenue was 74.446 + 74.521 + 73.216 + 79.934 = €302.1 Mil.
Market Cap (Today) was €270.9 Mil.
Total Liabilities was €180.1 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(117.337 - 40.97)/396.787
=0.1925

X2=Retained Earnings/Total Assets
=-10.485/396.787
=-0.0264

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-6.77 - -7.795)/396.787
=0.0026

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=270.929/180.068
=1.5046

X5=Revenue/Total Assets
=302.117/396.787
=0.7614

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Symmetry Surgical has a Altman Z-Score of 1.87 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Symmetry Surgical  (FRA:RZV) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Symmetry Surgical Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Symmetry Surgical (FRA:RZV) Business Description

Traded in Other Exchanges
N/A
Address
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.

Symmetry Surgical (FRA:RZV) Headlines